$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2011 Form 10-K Financial Statement

#000149229812000012 Filed on March 01, 2012

Income Statement

Concept	2011
Revenue	$84.23M
YoY Change	857.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$14.50M
YoY Change	806.25%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.59M
YoY Change	757.77%
% of Gross Profit
Operating Expenses	$41.10M
YoY Change	793.48%
Operating Profit
YoY Change
Interest Expense	-$30.30M
YoY Change	676.92%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$12.84M
YoY Change	6321.0%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$12.84M
YoY Change
Net Earnings / Revenue	15.25%
Basic Earnings Per Share	$0.43
Diluted Earnings Per Share	$0.43
COMMON SHARES
Basic Shares Outstanding	30.11M shares
Diluted Shares Outstanding	30.17M shares

Balance Sheet

Concept	2011
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.30M
YoY Change	-42.99%
Cash & Equivalents	$42.30M
Short-Term Investments
Other Short-Term Assets	$17.10M
YoY Change	42.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$59.40M
YoY Change	-31.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$653.4M
YoY Change	35.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$36.90M
YoY Change	19.03%
Total Long-Term Assets	$690.3M
YoY Change	34.46%
TOTAL ASSETS
Total Short-Term Assets	$59.40M
Total Long-Term Assets	$690.3M
Total Assets	$749.7M
YoY Change	25.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.10M
YoY Change	51.61%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$39.60M
YoY Change	11.24%
LONG-TERM LIABILITIES
Long-Term Debt	$378.9M
YoY Change	-1.94%
Other Long-Term Liabilities	$4.500M
YoY Change
Total Long-Term Liabilities	$383.4M
YoY Change	-0.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.60M
Total Long-Term Liabilities	$383.4M
Total Liabilities	$423.1M
YoY Change	0.26%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$326.6M
YoY Change
Total Liabilities & Shareholders Equity	$749.7M
YoY Change	25.03%

Cashflow Statement

Concept	2011
OPERATING ACTIVITIES
Net Income	$12.84M
YoY Change
Depreciation, Depletion And Amortization	$26.59M
YoY Change	757.77%
Cash From Operating Activities	$44.71M
YoY Change	577.35%
INVESTING ACTIVITIES
Capital Expenditures	-$204.5M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$204.6M
YoY Change	-404.9%
FINANCING ACTIVITIES
Cash Dividend Paid	$31.64M
YoY Change
Common Stock Issuance & Retirement, Net	$163.2M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$127.9M
YoY Change	25479.6%
NET CHANGE
Cash From Operating Activities	$44.71M
Cash From Investing Activities	-$204.6M
Cash From Financing Activities	$127.9M
Net Change In Cash	-$31.98M
YoY Change	-143.1%
FREE CASH FLOW
Cash From Operating Activities	$44.71M
Capital Expenditures	-$204.5M
Free Cash Flow	$249.2M
YoY Change	3675.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2010Q4	us-gaap	Revenues Revenues	8795000	USD
CY2010Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	9286000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	14139000	USD
CY2010Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	-7000	USD
CY2011Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	18791000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	344995000	USD
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	177275000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4600000	USD
CY2010Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	335000	USD
CY2011	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-15000	USD
CY2010Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-2000	USD
CY2010Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	230000	USD
CY2011	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1998000	USD
CY2010Q4	us-gaap	Assets Assets	599559000	USD
CY2011Q4	us-gaap	Assets Assets	749650000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74233000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42250000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-31983000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	74233000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2011	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.96
CY2011	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25061072	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36891712	shares
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25061072	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36891712	shares
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	251000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	369000	USD
CY2010Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	242000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	25540000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26300000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26591000	USD
CY2010Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3134000	USD
CY2011	us-gaap	Dividends Common Stock DividendsCommonStock	-31640000	USD
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2010Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2010Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14473000	USD
CY2010Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1553000	USD
CY2010Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	249000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12842000	USD
CY2010Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	242000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5695000	USD
CY2010Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3276000	USD
CY2011	us-gaap	Increase Decrease In Deferred Rent Receivables IncreaseDecreaseInDeferredRentReceivables	2092000	USD
CY2010Q4	us-gaap	Increase Decrease In Deferred Rent Receivables IncreaseDecreaseInDeferredRentReceivables	0	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1035000	USD
CY2010Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	609000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	3879000	USD
CY2010Q4	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	21000	USD
CY2010Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	3859000	USD
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	30319000	USD
CY2011	us-gaap	Interest Paid InterestPaid	28557000	USD
CY2010Q4	us-gaap	Interest Paid InterestPaid	760000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	422026000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	423077000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	749650000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	599559000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	127898000	USD
CY2010Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	523000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-204586000	USD
CY2010Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	67118000	USD
CY2010Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6592000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	44705000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	12842000	USD
CY2010Q4	us-gaap	Net Income Loss NetIncomeLoss	7000	USD
CY2011	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	80678000	USD
CY2010Q4	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	8781000	USD
CY2011	us-gaap	Payments Of Dividends PaymentsOfDividends	31640000	USD
CY2010Q4	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2010Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	161000	USD
CY2011	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	677000	USD
CY2011	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	86000	USD
CY2010Q4	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	16000	USD
CY2011	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5348000	USD
CY2010Q4	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2011	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	204500000	USD
CY2010Q4	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2010Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2011	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	5348000	USD
CY2010Q4	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	163242000	USD
CY2010Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2011	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	USD
CY2010Q4	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	10000000	USD
CY2010Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	88701	USD
CY2011Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	108916	USD
CY2011Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	658377000	USD
CY2010Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	482297000	USD
CY2010Q4	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	235000	USD
CY2011	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3027000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6093000	USD
CY2010Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4716000	USD
CY2011	us-gaap	Revenues Revenues	84225000	USD
CY2011Q4	us-gaap	Secured Debt SecuredDebt	158398000	USD
CY2010Q4	us-gaap	Secured Debt SecuredDebt	161440000	USD
CY2010Q4	us-gaap	Share Based Compensation ShareBasedCompensation	335000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	4600000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	163238000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	177533000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	326573000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	177191000	USD
CY2010Q4	us-gaap	Unsecured Debt UnsecuredDebt	225000000	USD
CY2011Q4	us-gaap	Unsecured Debt UnsecuredDebt	225000000	USD
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30171225	shares
CY2010Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25186988	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30109417	shares
CY2010Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25110936	shares
CY2011	sbra	Cash Received In Separation CashReceivedInSeparation	0	USD
CY2010Q4	sbra	Cash Received In Separation CashReceivedInSeparation	67134000	USD
CY2010Q4	sbra	Interest Income InterestIncome	14000	USD
CY2011	sbra	Interest Income InterestIncome	3547000	USD
CY2011Q4	sbra	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	25540000	USD
CY2010Q4	sbra	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	26300000	USD
CY2010Q4	sbra	Payment Of Separation Related Obligations PaymentOfSeparationRelatedObligations	9081000	USD
CY2011	sbra	Payment Of Separation Related Obligations PaymentOfSeparationRelatedObligations	0	USD
CY2010Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	12013000	USD
CY2011Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	17390000	USD
CY2011	sbra	Total Expenses TotalExpenses	71383000	USD
CY2010Q4	sbra	Total Expenses TotalExpenses	8546000	USD
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Document Type DocumentType	10-K
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2012Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36908166	shares
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2011	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2011Q2	dei	Entity Public Float EntityPublicFloat	412200000	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	Sabra Health Care REIT, Inc.
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No

Files In Submission

Name	View Source	Status
0001492298-12-000012-index-headers.html	Edgar Link	pending
0001492298-12-000012-index.html	Edgar Link	pending
0001492298-12-000012.txt	Edgar Link	pending
0001492298-12-000012-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20111231.xml	Edgar Link	completed
sbra-20111231.xsd	Edgar Link	pending
sbra-20111231_cal.xml	Edgar Link	unprocessable
sbra-20111231_def.xml	Edgar Link	unprocessable
sbra-20111231_lab.xml	Edgar Link	unprocessable
sbra-20111231_pre.xml	Edgar Link	unprocessable
sbra10k2011.htm	Edgar Link	pending
sbraex1212011.htm	Edgar Link	pending
sbraex211.htm	Edgar Link	pending
sbraex231.htm	Edgar Link	pending
sbraex3112011.htm	Edgar Link	pending
sbraex3122011.htm	Edgar Link	pending
sbraex3212011.htm	Edgar Link	pending
sbraex3222011.htm	Edgar Link	pending
Show.js	Edgar Link	pending
stockchart.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2011 Form 10-K Financial Statement

#000149229812000012 Filed on March 01, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2011 Form 10-K Financial Statement

#000149229812000012 Filed on March 01, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra